Alzheimer's disease
Investigators at Xi' An International Medical Center Hospital in Shanxi, People's Republic of China, have made groundbreaking discoveries in the fight against Alzheimer's disease. Their research, published in the European Journal of Medical Research, reveals that remimazolam (RMZ), a novel ultra-short-acting benzodiazepine, exhibits neuroprotective effects
Diseases
A recent study conducted by researchers at the Fuzong Clinical Medical College of Fujian Medical University has discovered a significant correlation between brain structural characteristics and early motor outcomes after deep brain stimulation (DBS) in patients with Parkinson's disease (PD). The study, published in the journal Quantitative Imaging
Alzheimer's disease
Research from the University of Southern California sheds light on the importance of considering site type when designing multisite preclinical Alzheimer's disease trials. The study compared recruitment and retention outcomes between academic and non-academic sites, yielding valuable insights for investigators. Key Takeaways: * Academic sites enrolled participants primarily through
Diseases
Researchers at Katholieke Universiteit Leuven have made a groundbreaking discovery in the field of neurodegenerative diseases, specifically Parkinson's Disease. The study evaluates the utility of evoked resonant neural activity (ERNA) as a physiologically grounded biomarker for optimizing deep brain stimulation (DBS) therapy. The researchers aimed to characterize ERNA&
Diseases
A recent Legionnaires' disease (LD) outbreak in the Strasbourg metropolitan area, France, has been linked to a collective biomass condensing boiler. The outbreak, which occurred between November 1 and December 12, 2019, resulted in 28 cases, with two fatalities. Epidemiological, environmental, and genomic investigations were conducted to identify the
Diseases
A team of researchers at Shanxi University in Taiyuan, People's Republic of China, has made a significant breakthrough in the field of epidemiology by developing an immuno-epidemiological model for Hand Foot and Mouth Disease (HFMD). The model, which intricately links host-to-host transmission, virus release, and recovery rates to
Diseases
Neuroscientists have made significant strides in understanding the complex neurodegenerative mechanisms underlying Parkinson's disease through a recent study utilizing magnetic resonance spectroscopy (MRS). The investigation, conducted at the All India Institute of Medical Sciences (AIIMS), sought to elucidate the role of the sensory motor cortex (SMC) in the
Diseases
Researchers from the Mario Negri Institute for Pharmacological Research in Bergamo, Italy, have shed new light on the classification and treatment of membranoproliferative glomerulonephritis (MPGN), a rare and complex kidney disease. By applying hierarchical clustering to a large cohort of patients, the team identified five distinct clusters with unique phenotypic
Diseases
Despite the unprecedented scientific and technological capacity to eradicate and reduce diseases of poverty, a substantial burden of preventable mortality and morbidity persists in low- and middle-income countries. A new study published by the California Institute of Behavioral Neurosciences & Psychology highlights the critical role of structural barriers in hindering
Diseases
The psychosis in Parkinson’s and Alzheimer’s Disease market presents a significant challenge for patients and caregivers, with symptoms of hallucinations and delusions significantly impacting patient quality of life. In Parkinson’s disease, psychosis affects 20-70% of patients, often emerging in later stages due to disease progression and dopaminergic
Diseases
Narcolepsy is a debilitating chronic sleep disorder that affects millions worldwide, including in Nigeria. Characterized by excessive daytime sleepiness, narcolepsy disrupts normal sleep-wake cycles and impairs daily life, relationships, and overall well-being. The condition is often misunderstood as laziness or oversleeping, but in reality, individuals with narcolepsy experience a faulty
Diseases
Scientists at Baylor College of Medicine have made significant progress in understanding how human Alzheimer's disease risk genes affect the brain. By studying fruit fly versions of 100 human Alzheimer's disease risk genes, researchers were able to determine the effects of these genes on the fly&
